MoneyWorks4Me

A fair growth of 15.74% in the revenue at Rs. 8092.00 millions was reported in the March 2024 quarter as compared to Rs. 6991.40 millions during year-ago period.A comparatively good net profit growth of 41.93% to Rs. 1258.50 millions was reported for the quarter ended March 2024 compared to Rs. 886.70 millions of previous same quarter.Operating profit surged to 2111.50 millions from the corresponding previous quarter of 1647.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 8092.00 6991.40 15.74 32986.40 28841.60 14.37 32986.40 28841.60 14.37
Other Income 161.00 33.00 387.88 346.80 86.50 300.92 346.80 86.50 300.92
PBIDT 2111.50 1647.40 28.17 9141.00 6733.40 35.76 9141.00 6733.40 35.76
Interest 83.20 122.60 -32.14 405.20 343.10 18.10 405.20 343.10 18.10
PBDT 2028.30 1524.80 33.02 8735.80 6390.30 36.70 8735.80 6390.30 36.70
Depreciation 397.20 305.60 29.97 1352.40 1119.90 20.76 1352.40 1119.90 20.76
PBT 1631.10 1219.20 33.78 7383.40 5270.40 40.09 7383.40 5270.40 40.09
TAX 372.60 332.50 12.06 1949.80 1381.50 41.14 1949.80 1381.50 41.14
Deferred Tax 93.40 109.00 -14.31 494.90 548.00 -9.69 494.90 548.00 -9.69
PAT 1258.50 886.70 41.93 5433.60 3888.90 39.72 5433.60 3888.90 39.72
Equity 155.20 154.80 0.26 155.20 154.80 0.26 155.20 154.80 0.26
PBIDTM(%) 26.09 23.56 10.74 27.71 23.35 18.70 27.71 23.35 18.70
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..